PCL, Inc. Logo

PCL, Inc.

241820.KQ

(0.0)
Stock Price

759,00 KRW

-21.49% ROA

-37.3% ROE

-4.31x PER

Market Cap.

68.047.800.000,00 KRW

35.78% DER

0% Yield

-193.1% NPM

PCL, Inc. Stock Analysis

PCL, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

PCL, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

6 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

PCL, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

PCL, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

PCL, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

PCL, Inc. Revenue
Year Revenue Growth
2015 243.021.670
2016 588.753.931 58.72%
2017 506.144.648 -16.32%
2018 128.540.945 -293.76%
2019 35.811.000 -258.94%
2020 53.682.669.587 99.93%
2021 46.147.521.837 -16.33%
2022 37.217.226.663 -24%
2023 2.448.264.000 -1420.15%
2023 8.429.532.300 70.96%
2024 1.381.384.236 -510.22%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

PCL, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2015 1.065.448.000
2016 2.346.502.000 54.59%
2017 1.367.555.000 -71.58%
2018 6.975.633.958 80.4%
2019 5.758.351.224 -21.14%
2020 11.009.637.000 47.7%
2021 4.825.824.000 -128.14%
2022 3.502.292.000 -37.79%
2023 1.396.348.000 -150.82%
2023 1.724.255.000 19.02%
2024 1.917.052.000 10.06%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

PCL, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2015 0
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 572.855.000 100%
2021 906.547.000 36.81%
2022 853.809.000 -6.18%
2023 13.860.000 -6060.24%
2023 808.069.000 98.28%
2024 12.280.040.000 93.42%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

PCL, Inc. EBITDA
Year EBITDA Growth
2015 -1.312.216.410
2016 -2.282.200.950 42.5%
2017 -3.840.652.430 40.58%
2018 -7.812.456.140 50.84%
2019 -8.441.735.240 7.45%
2020 23.627.725.350 135.73%
2021 -23.734.190.580 199.55%
2022 -5.717.250.130 -315.13%
2023 -14.201.049.200 59.74%
2023 -13.504.975.500 -5.15%
2024 -9.592.072.080 -40.79%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

PCL, Inc. Gross Profit
Year Gross Profit Growth
2015 83.013.100
2016 295.161.689 71.88%
2017 9.226.409 -3099.1%
2018 -558.493.693 101.65%
2019 -1.101.065.344 49.28%
2020 34.080.494.670 103.23%
2021 -11.794.447.640 388.95%
2022 6.186.550.635 290.65%
2023 -1.420.264.160 535.59%
2023 -4.158.659.521 65.85%
2024 -1.387.423.776 -199.74%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

PCL, Inc. Net Profit
Year Net Profit Growth
2015 -1.864.165.773
2016 -2.340.583.841 20.35%
2017 -3.869.221.755 39.51%
2018 -5.771.236.510 32.96%
2019 -7.965.850.469 27.55%
2020 19.508.749.390 140.83%
2021 -31.669.318.653 161.6%
2022 -4.017.547.977 -688.27%
2023 -19.297.969.240 79.18%
2023 -20.317.923.681 5.02%
2024 -12.983.069.148 -56.5%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

PCL, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2015 -62
2016 -78 20.51%
2017 -132 40.91%
2018 -192 31.25%
2019 -262 26.72%
2020 604 143.45%
2021 -930 164.91%
2022 -113 -722.12%
2023 -537 78.96%
2023 -500 -7.4%
2024 -229 -118.34%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

PCL, Inc. Free Cashflow
Year Free Cashflow Growth
2015 -1.982.369.843
2016 -3.168.953.155 37.44%
2017 -4.675.311.936 32.22%
2018 -8.019.804.588 41.7%
2019 -6.373.433.558 -25.83%
2020 -5.117.037.238 -24.55%
2021 -24.915.050.617 79.46%
2022 -3.803.224.030 -555.1%
2023 -2.926.336.370 -29.97%
2023 -8.176.816.283 64.21%
2024 -2.102.923.691 -288.83%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

PCL, Inc. Operating Cashflow
Year Operating Cashflow Growth
2015 -1.847.089.729
2016 -2.455.158.111 24.77%
2017 -3.622.436.613 32.22%
2018 -5.857.074.550 38.15%
2019 -5.120.499.351 -14.38%
2020 -2.286.705.821 -123.92%
2021 -16.224.740.219 85.91%
2022 -995.049.542 -1530.55%
2023 -986.736.370 -0.84%
2023 -4.916.651.196 79.93%
2024 -2.011.313.742 -144.45%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

PCL, Inc. Capital Expenditure
Year Capital Expenditure Growth
2015 135.280.114
2016 713.795.044 81.05%
2017 1.052.875.323 32.21%
2018 2.162.730.038 51.32%
2019 1.252.934.207 -72.61%
2020 2.830.331.417 55.73%
2021 8.690.310.398 67.43%
2022 2.808.174.488 -209.46%
2023 1.939.600.000 -44.78%
2023 3.260.165.087 40.51%
2024 91.609.949 -3458.75%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

PCL, Inc. Equity
Year Equity Growth
2015 4.988.681.124
2016 7.461.437.426 33.14%
2017 15.436.576.440 51.66%
2018 9.742.521.629 -58.45%
2019 5.821.878.930 -67.34%
2020 36.749.428.552 84.16%
2021 16.628.662.004 -121%
2022 33.643.619.336 50.57%
2023 37.611.061.131 10.55%
2023 21.142.524.480 -77.89%
2024 49.527.868.414 57.31%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

PCL, Inc. Assets
Year Assets Growth
2015 6.577.435.264
2016 8.902.743.993 26.12%
2017 15.873.793.160 43.92%
2018 10.620.981.459 -49.46%
2019 15.745.442.112 32.55%
2020 43.559.876.389 63.85%
2021 79.295.336.895 45.07%
2022 87.937.797.881 9.83%
2023 62.466.962.113 -40.77%
2023 56.374.161.000 -10.81%
2024 70.360.501.403 19.88%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

PCL, Inc. Liabilities
Year Liabilities Growth
2015 1.588.754.140
2016 1.441.306.567 -10.23%
2017 437.216.720 -229.65%
2018 878.459.830 50.23%
2019 9.923.563.182 91.15%
2020 6.810.447.837 -45.71%
2021 62.666.674.890 89.13%
2022 54.294.178.545 -15.42%
2023 24.855.900.982 -118.44%
2023 35.231.636.520 29.45%
2024 20.832.632.988 -69.12%

PCL, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
138.15
Net Income per Share
-266.76
Price to Earning Ratio
-4.31x
Price To Sales Ratio
8.69x
POCF Ratio
-6.47
PFCF Ratio
-6.52
Price to Book Ratio
1.37
EV to Sales
9.76
EV Over EBITDA
-6.19
EV to Operating CashFlow
-7.58
EV to FreeCashFlow
-7.32
Earnings Yield
-0.23
FreeCashFlow Yield
-0.15
Market Cap
68,05 Bil.
Enterprise Value
76,42 Bil.
Graham Number
2241.27
Graham NetNet
28.48

Income Statement Metrics

Net Income per Share
-266.76
Income Quality
0.67
ROE
-0.37
Return On Assets
-0.21
Return On Capital Employed
-0.27
Net Income per EBT
1.09
EBT Per Ebit
0.91
Ebit per Revenue
-1.94
Effective Tax Rate
-0.06

Margins

Sales, General, & Administrative to Revenue
0.97
Research & Developement to Revenue
0.22
Stock Based Compensation to Revenue
-0.01
Gross Profit Margin
-0.63
Operating Profit Margin
-1.94
Pretax Profit Margin
-1.77
Net Profit Margin
-1.93

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-177.78
Free CashFlow per Share
-184.12
Capex to Operating CashFlow
-0.04
Capex to Revenue
0.05
Capex to Depreciation
0.13
Return on Invested Capital
-0.25
Return on Tangible Assets
-0.21
Days Sales Outstanding
151.98
Days Payables Outstanding
1.82
Days of Inventory on Hand
268.54
Receivables Turnover
2.4
Payables Turnover
200.13
Inventory Turnover
1.36
Capex per Share
6.33

Balance Sheet

Cash per Share
269,93
Book Value per Share
873,87
Tangible Book Value per Share
873.87
Shareholders Equity per Share
836.92
Interest Debt per Share
326.18
Debt to Equity
0.36
Debt to Assets
0.24
Net Debt to EBITDA
-0.68
Current Ratio
2.34
Tangible Asset Value
49,53 Bil.
Net Current Asset Value
12,10 Bil.
Invested Capital
27453921593
Working Capital
18,85 Bil.
Intangibles to Total Assets
0
Average Receivables
4,15 Bil.
Average Payables
0,03 Bil.
Average Inventory
9285902775.5
Debt to Market Cap
0.25

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

PCL, Inc. Dividends
Year Dividends Growth

PCL, Inc. Profile

About PCL, Inc.

PCL, Inc. provides multiplex in vitro diagnostic (IVD) products and platform services. The company offers multiplex antibody and antigen diagnostic kits for the detection of antibodies to human immunodeficiency virus (HIV) 1 and 2, HBV, hepatitis C virus (HCV), and human T-lymphotropic virus 1 and 2, as well as antigens to HIV p24, HCV core, and HBV surface in human serum or plasma. It also provides Ai, an influenza A/B typing rapid diagnostic test kit; Cancer6, a multiple tumor markers screening kit; and sciLINER LATERAL FLOW DISPENSER, a dispenser for membrane materials with active visual drop volume control. In addition, the company offers platform services, such as sol-gel spotting service that immobilizes the customer's requested material using the SolB reagent; and SG ID service, which provides customers with a molecule of interest immobilized in the SolB reagent and identified. PCL, Inc. is headquartered in Seoul, South Korea.

CEO
Ms. Soyeon Kim
Employee
31
Address
Star valley, 99
Seoul, 08510

PCL, Inc. Executives & BODs

PCL, Inc. Executives & BODs
# Name Age
1 Ms. Soyeon Kim
Chief Executive Officer
70

PCL, Inc. Competitors

Seegene, Inc. Logo
Seegene, Inc.

096530.KQ

(0.0)
Boditech Med Inc. Logo
Boditech Med Inc.

206640.KQ

(0.0)
LabGenomics Co., Ltd. Logo
LabGenomics Co., Ltd.

084650.KQ

()
SD BioSensor, Inc Logo
SD BioSensor, Inc

137310.KS

(1.8)
Osstem Implant Co., Ltd. Logo
Osstem Implant Co., Ltd.

048260.KQ

(0.0)